Skip to main content
Erschienen in: Updates in Surgery 4/2021

05.04.2021 | Original Article

Micronvasive behaviour of single small hepatocellular carcinoma: which treatment?

verfasst von: Roberto Santambrogio, Matteo Barabino, Valentina D’Alessandro, Giulio Iacob, Enrico Opocher, Marco Gemma, Marco Antonio Zappa

Erschienen in: Updates in Surgery | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Microinvasion (MI), defined as infiltration of the portal or hepatic vein or bile duct and intrahepatic metastasis are accurate indicators of a poor prognosis for mall hepatocellular carcinomas (HCC). A previous study showed that intraoperative ultrasound (IOUS) definition of MI-HCC had a high concordance with histological findings. Aim of this study is to evaluate overall survival and recurrence patterns of patients with MI-HCC submitted to hepatic resection (HR) or laparoscopic ablation therapies (LAT).

Methods

A total of 171 consecutive patients (78 h; 93 LAT) with single, small HCC (< 3 cm) with a MI pattern at IOUS examination were compared analyzing overall survival and recurrence patterns using univariate and multivariate analysis and weighting by propensity score.

Results

Overall recurrences were similar in the 2 groups (HR: 51 patients (65%); LAT: 66 patients (71%)). The rate of local tumor progression in the HR group was very low (5 pts; 6%) in comparison to LAT group (22 pts; 24%; p = 0.002). The overall survival curves of HR are significantly better than that of the LAT group (p = 0.0039). On the propensity score Cox model, overall mortality was predicted by the surgical treatment with a Hazard ratio 1.68 (1.08–2.623) (p = 0.022).

Conclusions

If technically feasible and in patients fit for surgery, HR with an adequate tumor margin should be preferred to LAT in patients with MI-HCC at IOUS evaluation, to eradicate MI features near the main nodule, which are relatively frequent even in small HCC (< 3 cm).
Literatur
1.
Zurück zum Zitat Chen ZH, Zhang XP, Wang H, Chai ZT, Sun JX, Guo WX, Shi J, Cheng SQ (2019) Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis. HPB 21:935–944CrossRefPubMed Chen ZH, Zhang XP, Wang H, Chai ZT, Sun JX, Guo WX, Shi J, Cheng SQ (2019) Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis. HPB 21:935–944CrossRefPubMed
2.
Zurück zum Zitat Erstad DJ, Tanabe KK (2019) Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol 26:1474–1493CrossRefPubMed Erstad DJ, Tanabe KK (2019) Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol 26:1474–1493CrossRefPubMed
3.
Zurück zum Zitat Ferrer-Fabrega J, Forner A, Liccioni A, Miquel R, Molina V, Navasa M, Fondevila C, Garcia-Valdecasas JC, Bruix J, Fuster J (2016) Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection. Hepatology 63:839–849CrossRefPubMed Ferrer-Fabrega J, Forner A, Liccioni A, Miquel R, Molina V, Navasa M, Fondevila C, Garcia-Valdecasas JC, Bruix J, Fuster J (2016) Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection. Hepatology 63:839–849CrossRefPubMed
4.
Zurück zum Zitat Cillo U, Giuliani T, Polacco M, Herrero Manley LM, Crivellari G, Vitale A (2016) Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World J Gastroenterol 22:232–252CrossRefPubMedPubMedCentral Cillo U, Giuliani T, Polacco M, Herrero Manley LM, Crivellari G, Vitale A (2016) Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World J Gastroenterol 22:232–252CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Yamashita Y, Tsuijita E, Takeishi K, Fujiwara M, Kira S, Mori M, Aishima S, Taketomi A, Shirabe K, Ishida T, Maehara Y (2012) Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm. Ann Surg Oncol 19:2027–2034CrossRefPubMed Yamashita Y, Tsuijita E, Takeishi K, Fujiwara M, Kira S, Mori M, Aishima S, Taketomi A, Shirabe K, Ishida T, Maehara Y (2012) Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm. Ann Surg Oncol 19:2027–2034CrossRefPubMed
6.
Zurück zum Zitat Cucchetti A, Piscaglia F, Grigioni AD, Ravaioli M, Cescon M, Zanello M, Grazi GL, Golfieri R, Grigioni WF, Pinna AD (2010) Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. J Hepatol 52:880–888CrossRefPubMed Cucchetti A, Piscaglia F, Grigioni AD, Ravaioli M, Cescon M, Zanello M, Grazi GL, Golfieri R, Grigioni WF, Pinna AD (2010) Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. J Hepatol 52:880–888CrossRefPubMed
7.
Zurück zum Zitat Colecchia A, Scaioli E, Montrone L, Vestito A, Di Biase AR, Pieri M, D’Errico-Grgioni A, Bacchi-Reggiani ML, Ravaioli M, Grazi GL, Festi D (2011) Preoperative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment. J Hepatol 54:300–305CrossRefPubMed Colecchia A, Scaioli E, Montrone L, Vestito A, Di Biase AR, Pieri M, D’Errico-Grgioni A, Bacchi-Reggiani ML, Ravaioli M, Grazi GL, Festi D (2011) Preoperative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment. J Hepatol 54:300–305CrossRefPubMed
8.
Zurück zum Zitat Zhao J, Mao J, Li W (2019) Association of tumor grade with long-term survival in patients with hepatocellular carcinoma after liver transplantation. Transplant Proc 51:813–819CrossRefPubMed Zhao J, Mao J, Li W (2019) Association of tumor grade with long-term survival in patients with hepatocellular carcinoma after liver transplantation. Transplant Proc 51:813–819CrossRefPubMed
9.
Zurück zum Zitat Shen J, Liu J, Li C, Wen T, Yan L, Yang J (2018) The impact of tumor differentiation on the prognosis of HBV-associated solitary hepatocellular carcinoma following hepatectomy: a propensity score matching analysis. Dig Dis Sci 63:1962–1969CrossRefPubMed Shen J, Liu J, Li C, Wen T, Yan L, Yang J (2018) The impact of tumor differentiation on the prognosis of HBV-associated solitary hepatocellular carcinoma following hepatectomy: a propensity score matching analysis. Dig Dis Sci 63:1962–1969CrossRefPubMed
10.
Zurück zum Zitat Sasaki K, Matsuda M, Ohkura Y, Kawamura Y, Inoue M, Hashimoto M, Ikeda K, Kumada H, Watanabe G (2015) The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size. World J Surg 39:1134–1141CrossRefPubMed Sasaki K, Matsuda M, Ohkura Y, Kawamura Y, Inoue M, Hashimoto M, Ikeda K, Kumada H, Watanabe G (2015) The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size. World J Surg 39:1134–1141CrossRefPubMed
11.
Zurück zum Zitat Iguchi T, Shirabe K, Aishima S, Wang H, Fujita N, Ninomiya M, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T, Oda Y, Maehara Y (2015) New pathologic stratification of microvascular invasion in hepatocellular carcinoma: predicting prognosis after living-donor liver transplantation. Transplantation 99:1236–1242CrossRefPubMed Iguchi T, Shirabe K, Aishima S, Wang H, Fujita N, Ninomiya M, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T, Oda Y, Maehara Y (2015) New pathologic stratification of microvascular invasion in hepatocellular carcinoma: predicting prognosis after living-donor liver transplantation. Transplantation 99:1236–1242CrossRefPubMed
12.
Zurück zum Zitat Xu X, Zhang HL, Liu QP, Sun SW, Zhang J, Zhu FP, Yang G, Yan X, Zhang YD, Liu XS (2019) Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 70:1133–1144CrossRefPubMed Xu X, Zhang HL, Liu QP, Sun SW, Zhang J, Zhu FP, Yang G, Yan X, Zhang YD, Liu XS (2019) Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 70:1133–1144CrossRefPubMed
13.
Zurück zum Zitat Chen J, Zhou J, Kuang S, Zhang Y, Xie S, He B, Deng Y, Yang H, Shan Q, Wu J, Sirlin CB, Wang J (2019) Liver imaging reporting and data system category 5: MRI predictors of microvascular invasion and recurrence after hepatectomy for hepatocellular carcinoma. AJR 213:821–830CrossRefPubMed Chen J, Zhou J, Kuang S, Zhang Y, Xie S, He B, Deng Y, Yang H, Shan Q, Wu J, Sirlin CB, Wang J (2019) Liver imaging reporting and data system category 5: MRI predictors of microvascular invasion and recurrence after hepatectomy for hepatocellular carcinoma. AJR 213:821–830CrossRefPubMed
14.
Zurück zum Zitat Hu HT, Wang Z, Huang XW, Chen SL, Zheng X, Ruan SM, Xie XY, Lu MD, Yu J, Tian J, Liang P, Kuang M (2019) Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma. Eur Radiol 29:2890–2901CrossRefPubMed Hu HT, Wang Z, Huang XW, Chen SL, Zheng X, Ruan SM, Xie XY, Lu MD, Yu J, Tian J, Liang P, Kuang M (2019) Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma. Eur Radiol 29:2890–2901CrossRefPubMed
15.
Zurück zum Zitat Santambrogio R, Cigala C, Maggioni BM, M, Scifo G, Bruno S, Bertolini E, Opocher E, Bulfamante G, (2018) Intraoperative ultrasound for prediction of hepatocellular carcinoma biological behavior: prospective comparison with pathology. Liver Int 38:312–320CrossRefPubMed Santambrogio R, Cigala C, Maggioni BM, M, Scifo G, Bruno S, Bertolini E, Opocher E, Bulfamante G, (2018) Intraoperative ultrasound for prediction of hepatocellular carcinoma biological behavior: prospective comparison with pathology. Liver Int 38:312–320CrossRefPubMed
16.
Zurück zum Zitat Santambrogio R, Barabino M, De Nicola E, Galfrascoli E, Giovenzana M, Zappa MA (2020) Laparoscopic ablation therapies for hepatocellular carcinoma: could specific indications for the laparoscopic approach influence the effectiveness? Surg Endosc 16:349–354CrossRef Santambrogio R, Barabino M, De Nicola E, Galfrascoli E, Giovenzana M, Zappa MA (2020) Laparoscopic ablation therapies for hepatocellular carcinoma: could specific indications for the laparoscopic approach influence the effectiveness? Surg Endosc 16:349–354CrossRef
17.
18.
Zurück zum Zitat Santambrogio R, Kluger MD, Costa M, Belli A, Barabino M, Laurent A, Opocher E, Azoulay D, Cherqui D (2013) Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh’s A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB 15:78–84CrossRefPubMed Santambrogio R, Kluger MD, Costa M, Belli A, Barabino M, Laurent A, Opocher E, Azoulay D, Cherqui D (2013) Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh’s A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB 15:78–84CrossRefPubMed
19.
Zurück zum Zitat Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R (1973) Transection of the esophagus for bleeding esophageal varices. Br J Surg 60:646–649CrossRefPubMed Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R (1973) Transection of the esophagus for bleeding esophageal varices. Br J Surg 60:646–649CrossRefPubMed
20.
Zurück zum Zitat Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lock AS (2005) Prognosis of hepatocellular carcinoma: Comparison of seven staging systems in an American cohort. Hepatology 41:707–716CrossRefPubMed Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lock AS (2005) Prognosis of hepatocellular carcinoma: Comparison of seven staging systems in an American cohort. Hepatology 41:707–716CrossRefPubMed
21.
Zurück zum Zitat Santambrogio R, Costa M, Strada D, Bertolini E, Zuin M, Barabino M, Opocher E (2011) Intraoperative ultrasound score to predict recurrent hepatocellular carcinoma after radical treatments. Ultrasound Med Biol 37:7–15CrossRefPubMed Santambrogio R, Costa M, Strada D, Bertolini E, Zuin M, Barabino M, Opocher E (2011) Intraoperative ultrasound score to predict recurrent hepatocellular carcinoma after radical treatments. Ultrasound Med Biol 37:7–15CrossRefPubMed
22.
Zurück zum Zitat Santambrogio R, Bruno S, Kluger CM, Salceda J, Belli A, Laurent A, Barabino M, Opocher E, Azoulay D, Cherqui D (2016) Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma. Dig Liver Dis 48:189–196CrossRefPubMed Santambrogio R, Bruno S, Kluger CM, Salceda J, Belli A, Laurent A, Barabino M, Opocher E, Azoulay D, Cherqui D (2016) Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma. Dig Liver Dis 48:189–196CrossRefPubMed
23.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications. A new proposal with evaluation in a cohort of 633 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications. A new proposal with evaluation in a cohort of 633 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Ahmed M (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology 273:241–260CrossRefPubMed Ahmed M (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology 273:241–260CrossRefPubMed
25.
Zurück zum Zitat Hajage D, Chauvet G, Belin L, Lafourcade A, Tubach F, De Rycke Y (2018) Closed-form variance estimator for weighted propensity score estimators with survival outcome. Biom J 60:1151–1163CrossRefPubMed Hajage D, Chauvet G, Belin L, Lafourcade A, Tubach F, De Rycke Y (2018) Closed-form variance estimator for weighted propensity score estimators with survival outcome. Biom J 60:1151–1163CrossRefPubMed
27.
Zurück zum Zitat Zhu YJ, Feng B, Wang S, Wang LM, Wu JF, Ma XH, Zhao XM (2019) Model-based three-dimensional texture analysis of contrast-enhanced magnetic resonance imaging as a potential tool for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Oncol Let 18:720–732 Zhu YJ, Feng B, Wang S, Wang LM, Wu JF, Ma XH, Zhao XM (2019) Model-based three-dimensional texture analysis of contrast-enhanced magnetic resonance imaging as a potential tool for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Oncol Let 18:720–732
28.
Zurück zum Zitat Wang H, Wu MC, Cong WM (2019) Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis. Hepatol Res 49:344–354CrossRefPubMed Wang H, Wu MC, Cong WM (2019) Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis. Hepatol Res 49:344–354CrossRefPubMed
29.
Zurück zum Zitat Han J, Li ZL, Xing H, Wu H, Zhu P, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Wu MC, Shen F, Yang T (2019) The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study. HPB 21:962–971CrossRefPubMed Han J, Li ZL, Xing H, Wu H, Zhu P, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Wu MC, Shen F, Yang T (2019) The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study. HPB 21:962–971CrossRefPubMed
30.
Zurück zum Zitat Hidaka M, Eguchi S, Okuda K, Beppu T, Shirabe K, Kondo K, Takami Y, Ohta M, Shiraishi M, Ueno S, Nanashima A, Noritomi T, Kitahara K, Fujioka H (2020) Impact of anatomical resection for hepatocellular carcinoma with microportal invasion (vp1). A multi-institutional study by the Kyushu Group of Liver Surgery. Ann Surg 271:339–346CrossRefPubMed Hidaka M, Eguchi S, Okuda K, Beppu T, Shirabe K, Kondo K, Takami Y, Ohta M, Shiraishi M, Ueno S, Nanashima A, Noritomi T, Kitahara K, Fujioka H (2020) Impact of anatomical resection for hepatocellular carcinoma with microportal invasion (vp1). A multi-institutional study by the Kyushu Group of Liver Surgery. Ann Surg 271:339–346CrossRefPubMed
33.
Zurück zum Zitat Rossi S, Ravetta V, Rosa L, Ghittoni G, Torello Viera F, Garbagnati F, Silini EM, Dionigi P, Calliada F, Quaretti P, Tinelli C (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study 53:136–147 Rossi S, Ravetta V, Rosa L, Ghittoni G, Torello Viera F, Garbagnati F, Silini EM, Dionigi P, Calliada F, Quaretti P, Tinelli C (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study 53:136–147
34.
Zurück zum Zitat Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI (2014) Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 270:900–909CrossRefPubMed Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI (2014) Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 270:900–909CrossRefPubMed
35.
Zurück zum Zitat Sparchez Z, Mocan T, Radu P, Mocan LP, Sparchez M, Leucuta DC, Al HN (2018) Prognostic factors after percutaneous ablation in the treatment of hepatocellular carcinoma. Impact of incomplete ablation on recurrence and overall survival rates. J Gastrointestin Liver Dis 27:399–407CrossRefPubMed Sparchez Z, Mocan T, Radu P, Mocan LP, Sparchez M, Leucuta DC, Al HN (2018) Prognostic factors after percutaneous ablation in the treatment of hepatocellular carcinoma. Impact of incomplete ablation on recurrence and overall survival rates. J Gastrointestin Liver Dis 27:399–407CrossRefPubMed
36.
Zurück zum Zitat Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, Xu ZF, Liu GJ (2005) Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. Clin Radiol 60:1018–1025CrossRefPubMed Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, Xu ZF, Liu GJ (2005) Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. Clin Radiol 60:1018–1025CrossRefPubMed
37.
Zurück zum Zitat Santambrogio R, Salceda J, Costa M, Kluger MD, Barabino M, Laurent A, Opocher E, Azoulay D, Cherqui D (2013) External validation of a simplified BCLC staging system for early hepatocellular carcinoma. EJSO 39:850–857CrossRefPubMed Santambrogio R, Salceda J, Costa M, Kluger MD, Barabino M, Laurent A, Opocher E, Azoulay D, Cherqui D (2013) External validation of a simplified BCLC staging system for early hepatocellular carcinoma. EJSO 39:850–857CrossRefPubMed
38.
Zurück zum Zitat Cillo U, Bertacco A, Fasolo E, Carandina R, Vitale A, Zanus G, Gringeri E, D’Amico F, Bassi D, Neri D, Dadduzio V, Farinati F, Aliberti C (2019) Videolaparoscopic microwave ablation in patients with HCC at a European high-volume cnter: results of 815 procedures. J Surg Oncol 120:956–965CrossRefPubMed Cillo U, Bertacco A, Fasolo E, Carandina R, Vitale A, Zanus G, Gringeri E, D’Amico F, Bassi D, Neri D, Dadduzio V, Farinati F, Aliberti C (2019) Videolaparoscopic microwave ablation in patients with HCC at a European high-volume cnter: results of 815 procedures. J Surg Oncol 120:956–965CrossRefPubMed
39.
Zurück zum Zitat Vibert E, Schwartz M, Olthoff KM (2020) Advances in resection and transplantation for hepatocellular carcinoma. J Hepatol 72:262–276CrossRefPubMed Vibert E, Schwartz M, Olthoff KM (2020) Advances in resection and transplantation for hepatocellular carcinoma. J Hepatol 72:262–276CrossRefPubMed
Metadaten
Titel
Micronvasive behaviour of single small hepatocellular carcinoma: which treatment?
verfasst von
Roberto Santambrogio
Matteo Barabino
Valentina D’Alessandro
Giulio Iacob
Enrico Opocher
Marco Gemma
Marco Antonio Zappa
Publikationsdatum
05.04.2021
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 4/2021
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-021-01036-0

Weitere Artikel der Ausgabe 4/2021

Updates in Surgery 4/2021 Zur Ausgabe

Letter to the Editor

Letter to the editor

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.